Craig R Lee, PhD, PharmD

University of North Carolina at Chapel Hill
Chapel Hill, NC
USA

Papers:

Association of CYP2C19*17 Allele and Choice of P2Y12 Inhibitor on Cardiovascular Outcomes Following Percutaneous Coronary Intervention